Nuveen Asset Management, LLC Cytosorbents Corp Transaction History

Nuveen Asset Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.22 $237,835 - $435,131	-135,134 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.88 - $4.23 $3,274 - $4,809	1,137 Added 0.85%	135,134 $420,000
Q4 2021 Feb 14, 2022	SELL	$4.05 - $8.11 $55,845 - $111,828	-13,789 Reduced 9.33%	133,997 $594,000
Q3 2021 Nov 12, 2021	SELL	$7.0 - $9.71 $29,953 - $41,549	-4,279 Reduced 2.81%	147,786 $1.29 Million
Q2 2021 Aug 16, 2021	SELL	$7.55 - $9.42 $72,004 - $89,838	-9,537 Reduced 5.9%	152,065 $1.15 Million

Q1 2021 May 17, 2021	BUY	$8.23 - $11.48 $7,579 - $10,573	921 Added 0.57%	161,602 $1.4 Million
Q4 2020 Feb 16, 2021	BUY	$7.65 - $8.98 $90,147 - $105,820	11,784 Added 7.91%	160,681 $1.28 Million
Q3 2020 Nov 16, 2020	BUY	$7.37 - $11.54 $56,063 - $87,784	7,607 Added 5.38%	148,897 $1.19 Million
Q2 2020 Aug 14, 2020	BUY	$6.28 - $10.59 $129,248 - $217,952	20,581 Added 17.05%	141,290 $1.4 Million
Q1 2020 May 14, 2020	BUY	$3.77 - $7.73 $38,872 - $79,704	10,311 Added 9.34%	120,709 $933,000
Q3 2019 Nov 14, 2019	SELL	$4.33 - $7.63 $26,625 - $46,916	-6,149 Reduced 5.28%	110,398 $555,000
Q2 2019 Aug 15, 2019	BUY	$5.92 - $7.78 $689,958 - $906,735	116,547 New	116,547 $770,000

17.8M

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $39.7M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.